These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 354136)
21. Human T-lymphocyte receptors for sheep erythrocyte, antithymocyte (ATG), and anti-human brain globulins (AHB) in renal allograft recipients. Parsa I; Butt KM; Elberg AJ; Kountz SL; Satoh PS; Sutton A Transplant Proc; 1979 Jun; 11(2):1241-5. PubMed ID: 382498 [No Abstract] [Full Text] [Related]
22. Histocompatibility-dependent long-term islet of Langerhans survival induced by antithymocyte globulin. Beyer MM; Friedman EA Transplant Proc; 1979 Jun; 11(2):1436-9. PubMed ID: 112739 [No Abstract] [Full Text] [Related]
23. The flow cytometry crossmatch in kidney transplantation. Cook DJ; Terasaki PI; Iwaki Y; Terashita G; Takeda A; Fujikawa J; Lau M; Danovitch G; Rosenthal JT; Fine R Clin Transpl; 1987; ():409-14. PubMed ID: 3154440 [TBL] [Abstract][Full Text] [Related]
24. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody. Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462 [TBL] [Abstract][Full Text] [Related]
25. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. Cosimi AB; Wortis HH; Delmonico FL; Russell PS Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887 [TBL] [Abstract][Full Text] [Related]
26. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates. García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847 [No Abstract] [Full Text] [Related]
27. Effects of different ATG (ATGAM) regimens on levels of rosette-forming cells (RFC), serum horse IgG (HoI), and anti-horse antibodies in kidney transplant patients. Satoh P; Elberg A; Davis J; Uittenbogaart C; Fine R; Hardy MA Transplant Proc; 1979 Jun; 11(2):1427-8. PubMed ID: 382530 [No Abstract] [Full Text] [Related]
29. Use of antiglobulin microcytotoxicity test and mixed leukocyte culture to evaluate prognosis in renal transplant recipients. Farrow SS; Rossen RD; Suki WN; Hersh EM Proc Clin Dial Transplant Forum; 1973; 3():74-6. PubMed ID: 4283133 [No Abstract] [Full Text] [Related]
30. Differential effects of horse ATG and rabbit ATG on T cell and T cell subset levels measured by monoclonal antibodies. Thomas FT; Griesedieck C; Thomas J; Carver M; Whitley T; Warren R; Williams D Transplant Proc; 1984 Dec; 16(6):1561-3. PubMed ID: 6239426 [No Abstract] [Full Text] [Related]
31. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex. Wasfie T; Reed E; Suciu-Foca N; Hardy MA Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319 [TBL] [Abstract][Full Text] [Related]
32. HLA-DR matching and B-cell crossmatching in renal transplantation. Ting A; Williams KA; Morris PJ Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181 [No Abstract] [Full Text] [Related]
33. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts. Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247 [TBL] [Abstract][Full Text] [Related]
34. Flow cytometry crossmatching for kidney transplantation. Cook DJ; Terasaki PI; Iwaki Y; Terashita G; Fujikawa J; Gera J; Takeda A; Danovitch G; Rosenthal JT; Fine R Clin Transpl; 1988; ():375-80. PubMed ID: 3154487 [TBL] [Abstract][Full Text] [Related]
35. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching. Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324 [No Abstract] [Full Text] [Related]
36. Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival. Thomas JM; Carver FM; Cunningham PR; Gross U; Verbanac KM; Rebellato LM; Riley R; Thomas FT Transplant Proc; 1993 Feb; 25(1 Pt 1):342-3. PubMed ID: 8438326 [No Abstract] [Full Text] [Related]
37. Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches. Noreen HJ; van der Hagen E; Bach FH; Fryd D; Ascher N; Simmons RL; Najarian JS Transplant Proc; 1987 Feb; 19(1 Pt 1):780-1. PubMed ID: 3274873 [No Abstract] [Full Text] [Related]
38. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts. Reed E; Cohen DJ; Barr ML; Ho E; Marboe CC; Rose EA; Hardy M; Suciu-Foca N Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842 [TBL] [Abstract][Full Text] [Related]
39. Prolonged allograft survival of strong pretransplant immune responders treated with ATG. Kerman RH; Floyd M; Van Buren CT; Kahan BD Transplant Proc; 1981 Mar; 13(1 Pt 1):332-5. PubMed ID: 6455793 [No Abstract] [Full Text] [Related]